Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Cleveland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
This phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based therapy. Cisplatin-based therapy is the standard of care for patients with MIBC. However, many patients cannot receive standard therapy due to poor renal function, peripheral neuropathy, poor functional status, or clinically significant heart failure. Futibatinib may stop the growth of
Sponsor: Yuanquan Yang
Check if you qualify for this bladder cancer clinical trial in Cleveland, OH
If you're searching for bladder cancer treatment options in Cleveland, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.